Literature DB >> 22469351

Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Jeffrey J Pasternak1, Eric E Williamson.   

Abstract

Iodinated contrast agents have been in use since the 1950s to facilitate radiographic imaging modalities. Physicians in almost all specialties will either administer these agents or care for patients who have received these drugs. Different iodinated contrast agents vary greatly in their properties, uses, and toxic effects. Therefore, clinicians should be at least superficially familiar with the clinical pharmacology, administration, risks, and adverse effects associated with iodinated contrast agents. This primer offers the non-radiologist physician the opportunity to gain insight into the use of this class of drugs.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469351      PMCID: PMC3538464          DOI: 10.1016/j.mayocp.2012.01.012

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  75 in total

1.  Anaphylactoid reaction to oral contrast for computed tomography.

Authors:  Christopher W Seymour; John P Pryor; Rajan Gupta; C William Schwab
Journal:  J Trauma       Date:  2004-11

Review 2.  X-ray contrast media--an overview.

Authors:  Cathrine Christiansen
Journal:  Toxicology       Date:  2005-04-15       Impact factor: 4.221

Review 3.  Adverse reactions to drugs.

Authors:  D Vervloet; S Durham
Journal:  BMJ       Date:  1998-05-16

Review 4.  Allergic reactions to oral iodinated contrast agents: reactions to oral contrast.

Authors:  L J Ridley
Journal:  Australas Radiol       Date:  1998-05

5.  Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.

Authors:  H Watanabe; H Sueki; T Nakada; M Akiyama; M Iijima
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

Review 6.  Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 7.  Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies.

Authors:  Ilan Goldenberg; Shlomi Matetzky
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

8.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.

Authors:  M A Stevens; P A McCullough; K J Tobin; J P Speck; D C Westveer; D A Guido-Allen; G C Timmis; W W O'Neill
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

9.  PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction.

Authors:  A J Taylor; D Hotchkiss; R W Morse; J McCabe
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

10.  Mechanisms of severe, immediate reactions to iodinated contrast material.

Authors:  D Laroche; I Aimone-Gastin; F Dubois; H Huet; P Gérard; M C Vergnaud; C Mouton-Faivre; J L Guéant; M C Laxenaire; H Bricard
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

View more
  28 in total

1.  In vivo performance of gold nanoparticle-loaded absorbable inferior vena cava filters in a swine model.

Authors:  Steven Y Huang; Jossana A Damasco; Li Tian; Linfeng Lu; Joy Vanessa D Perez; Katherine A Dixon; Malea L Williams; Megan C Jacobsen; Stephen J Dria; Mitchell D Eggers; Adam D Melancon; Rick R Layman; Elizabeth M Whitley; Marites P Melancon
Journal:  Biomater Sci       Date:  2020-06-19       Impact factor: 6.843

2.  Diagnostic and Therapeutic Nanomedicine.

Authors:  Jinmyoung Joo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Updated guidelines for intravenous contrast use for CT and MRI.

Authors:  Kevin Huynh; Arthur H Baghdanian; Armonde A Baghdanian; Derek S Sun; K Pallav Kolli; Ronald J Zagoria
Journal:  Emerg Radiol       Date:  2020-01-10

4.  Recent Advances in Molecular Imaging with Gold Nanoparticles.

Authors:  Mathilde Bouché; Jessica C Hsu; Yuxi C Dong; Johoon Kim; Kimberly Taing; David P Cormode
Journal:  Bioconjug Chem       Date:  2019-11-13       Impact factor: 4.774

5.  Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.

Authors:  Ji-Yan Chen; Yong Liu; Ying-Ling Zhou; Ning Tan; Bin Zhang; Ping-Yan Chen; Li-Bing Chen
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-10       Impact factor: 2.357

Review 6.  Iobitridol: a review of its use as a contrast medium in diagnostic imaging.

Authors:  Paul L McCormack
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

7.  Contrast induced neurotoxicity following coronary angiogram with Iohexol in an end stage renal disease patient.

Authors:  Narasimha Swamy Gollol Raju; Deepak Joshi; Ramesh Daggubati; Assad Movahed
Journal:  World J Clin Cases       Date:  2015-11-16       Impact factor: 1.337

8.  Acute Pulmonary Embolism: Contemporary Approach to Diagnosis, Risk-Stratification, and Management.

Authors:  Tahir Tak; Swetha Karturi; Umesh Sharma; Lee Eckstein; Joseph T Poterucha; Yader Sandoval
Journal:  Int J Angiol       Date:  2019-07-05

9.  Transthoracic echocardiography as an alternative major guidance to angiography during transcatheter closure of patent ductus arteriosus: technical feasibility and clinical relevance.

Authors:  Wanhua Chen; Xiaoping Yan; Yu Huang; Xudong Sun; Ling Zhong; Jinguo Li; Hua Chen; Huiying Zhong; Lianglong Chen
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

Review 10.  Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.

Authors:  Rakesh D Bansie; A Faiz Karim; Maurits S van Maaren; Maud Aw Hermans; Paul LA van Daele; Roy Gerth van Wijk; Saskia M Rombach
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.